These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 28965629)
1. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease. Magro CM; Olson LC; Fulmer CG Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up and management of small and medium-sized CD4 Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of follicular T-helper cells in primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma and dermatitis. Ally MS; Prasad Hunasehally RY; Rodriguez-Justo M; Martin B; Verdolini R; Attard N; Child F; Attygalle A; Whittaker S; Morris S; Robson A J Cutan Pathol; 2013 Dec; 40(12):1006-13. PubMed ID: 24274425 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells. Zhang L; Shao H J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694 [TBL] [Abstract][Full Text] [Related]
5. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. Wang L; Wang G; Gao T J Cutan Pathol; 2015 Apr; 42(4):265-70. PubMed ID: 25407448 [TBL] [Abstract][Full Text] [Related]
6. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Cetinözman F; Jansen PM; Willemze R Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders. Magro CM; Ruan J; Grossman M; Hedayat AA Ann Diagn Pathol; 2019 Jun; 40():94-104. PubMed ID: 31077877 [TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Beltraminelli H; Leinweber B; Kerl H; Cerroni L Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234 [TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category. Williams VL; Torres-Cabala CA; Duvic M Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906 [TBL] [Abstract][Full Text] [Related]
10. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791 [TBL] [Abstract][Full Text] [Related]
11. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992 [TBL] [Abstract][Full Text] [Related]
13. Primary Cutaneous CD4 Maurelli M; Colato C; Gisondi P; Girolomoni G J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998 [TBL] [Abstract][Full Text] [Related]
14. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells. Jacyk WK; Grayson W; Dinkel JE; Requena L J Cutan Pathol; 2007 Aug; 34(8):644-7. PubMed ID: 17640236 [TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914 [TBL] [Abstract][Full Text] [Related]
16. Post-thymic CD4 positive cytotoxic T cell infiltrates of the skin: A clinical and histomorphologic spectrum of the unique CD4 positive T cell of immunosenescence. Magro CM; Olson LC; Momtahen S Ann Diagn Pathol; 2019 Feb; 38():99-105. PubMed ID: 30572149 [TBL] [Abstract][Full Text] [Related]
17. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series. Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases. Plaza JA; Feldman AL; Magro C J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966 [TBL] [Abstract][Full Text] [Related]
19. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma. Magro CM; Momtahen S Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342 [TBL] [Abstract][Full Text] [Related]
20. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin. Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]